These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26820419)

  • 1. Medication and creativity in Attention Deficit Hyperactivity Disorder (ADHD).
    González-Carpio Hernández G; Serrano Selva JP
    Psicothema; 2016; 28(1):20-5. PubMed ID: 26820419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attention deficit hyperactivity disorder, creativity, and the effects of methylphenidate.
    Funk JB; Chessare JB; Weaver MT; Exley AR
    Pediatrics; 1993 Apr; 91(4):816-9. PubMed ID: 8464673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of stimulant medication on divergent and convergent thinking tasks related to creativity in adults with attention-deficit hyperactivity disorder.
    McBride M; Appling C; Ferguson B; Gonzalez A; Schaeffer A; Zand A; Wang D; Sam A; Hart E; Tosh A; Fontcha I; Parmacek S; Beversdorf D
    Psychopharmacology (Berl); 2021 Dec; 238(12):3533-3541. PubMed ID: 34477886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of methylphenidate on multiple components of attention in children with attention deficit hyperactivity disorder.
    Tucha O; Prell S; Mecklinger L; Bormann-Kischkel C; Kübber S; Linder M; Walitza S; Lange KW
    Psychopharmacology (Berl); 2006 Apr; 185(3):315-26. PubMed ID: 16521033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of methylphenidate on acute math performance in children with attention-deficit hyperactivity disorder.
    Grizenko N; Cai E; Jolicoeur C; Ter-Stepanian M; Joober R
    Can J Psychiatry; 2013 Nov; 58(11):632-9. PubMed ID: 24246434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Empathy and Facial Expression Recognition in Children With and Without Attention-Deficit/Hyperactivity Disorder: Effects of Stimulant Medication on Empathic Skills in Children with Attention-Deficit/Hyperactivity Disorder.
    Gumustas F; Yilmaz I; Yulaf Y; Gokce S; Sabuncuoglu O
    J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):433-439. PubMed ID: 28332851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of methylphenidate on body index and physical fitness in Korean children with attention deficit hyperactivity disorder.
    Kang KD; Yun SW; Chung U; Kim TH; Park JH; Park IH; Han DH
    Hum Psychopharmacol; 2016 Mar; 31(2):76-82. PubMed ID: 26756111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
    Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S
    CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting methylphenidate response in attention deficit hyperactivity disorder: a preliminary study.
    Johnston BA; Coghill D; Matthews K; Steele JD
    J Psychopharmacol; 2015 Jan; 29(1):24-30. PubMed ID: 25237119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of two long-acting methylphenidate formulations in children with attention- deficit/hyperactivity disorder in a laboratory classroom setting.
    Silva R; Muniz R; Pestreich LK; Brams M; Childress A; Lopez FA
    J Child Adolesc Psychopharmacol; 2005 Aug; 15(4):637-54. PubMed ID: 16190795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between dopamine transporter (DAT1) genotype, left-sided inattention, and an enhanced response to methylphenidate in attention-deficit hyperactivity disorder.
    Bellgrove MA; Hawi Z; Kirley A; Fitzgerald M; Gill M; Robertson IH
    Neuropsychopharmacology; 2005 Dec; 30(12):2290-7. PubMed ID: 16123773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroimaging-Aided Prediction of the Effect of Methylphenidate in Children with Attention-Deficit Hyperactivity Disorder: A Randomized Controlled Trial.
    Ishii-Takahashi A; Takizawa R; Nishimura Y; Kawakubo Y; Hamada K; Okuhata S; Kawasaki S; Kuwabara H; Shimada T; Todokoro A; Igarashi T; Watanabe K; Yamasue H; Kato N; Kasai K; Kano Y
    Neuropsychopharmacology; 2015 Nov; 40(12):2676-85. PubMed ID: 25936640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
    Chou WJ; Chou MC; Tzang RF; Hsu YC; Gau SS; Chen SJ; Wu YY; Huang YF; Liang HY; Cheng H
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once-daily multilayer-release methylphenidate in a double-blind, crossover comparison to immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder.
    Weiss M; Hechtman L; Turgay A; Jain U; Quinn D; Ahmed TS; Yates T; Reiz JL; Donnelly GA; Harsanyi Z; Darke AC
    J Child Adolesc Psychopharmacol; 2007 Oct; 17(5):675-88. PubMed ID: 17979587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylphenidate improves some but not all measures of attention, as measured by the TEA-Ch in medication-naïve children with ADHD.
    Paton K; Hammond P; Barry E; Fitzgerald M; McNicholas F; Kirley A; Robertson IH; Bellgrove MA; Gill M; Johnson KA
    Child Neuropsychol; 2014; 20(3):303-18. PubMed ID: 23639119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and therapeutic effect of OROS methylphenidate under different breakfast conditions in children with attention-deficit/hyperactivity disorder.
    Wigal SB; Gupta S; Heverin E; Starr HL
    J Child Adolesc Psychopharmacol; 2011 Jun; 21(3):255-63. PubMed ID: 21663428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attention-deficit/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study.
    Huang YS; Guilleminault C; Li HY; Yang CM; Wu YY; Chen NH
    Sleep Med; 2007 Jan; 8(1):18-30. PubMed ID: 17157069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attention-deficit/hyperactivity disorder and comorbid subsyndromal depression: what is the impact of methylphenidate on mood?
    Golubchik P; Kodesh A; Weizman A
    Clin Neuropharmacol; 2013; 36(5):141-5. PubMed ID: 24045603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylphenidate combined with aripiprazole in children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder: a randomized crossover trial.
    Zeni CP; Tramontina S; Ketzer CR; Pheula GF; Rohde LA
    J Child Adolesc Psychopharmacol; 2009 Oct; 19(5):553-61. PubMed ID: 19877980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naïve children with ADHD during a rewarded continuous performance task.
    Rubia K; Halari R; Cubillo A; Mohammad AM; Brammer M; Taylor E
    Neuropharmacology; 2009 Dec; 57(7-8):640-52. PubMed ID: 19715709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.